qwertyuiopasdfghjklzxcvbnmqwerty uiopasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjklzx cvbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmqwertyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg NIFTY OUTLOOK hjklzxcvbnmqwertyuiopasdfghjklzxc REPORT vbnmqwertyuiopasdfghjklzxcvbnmq 12 July 2017 wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmrtyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqwert yuiopasdfghjklzxcvbnmqwertyuiopas th
12th July 2017
NIFTY
NIFTY FUT : PIVOT : 9798
R1:9826 S1:9768
R2:9860 S2:9750
R3:9900 S3:9730
NIFTY INTRADAY CHART NIFTY OUTLOOK Nifty is likely to open in a marginal positive note. Bears are dragged by the bulls and we are expecting they will be dragged till 9990.Momentum indicators are indicating towards bullish trading sessions ahead. Positional traders are advised to cover their longs and get ready to make new shorts around 9990 with a very small stop loss of 10101 for the target of 9600.Intraday traders are advised to adopt buy on dips strategy for the day. Strategy: buy nifty around 9760 with a stop loss of 9720 for the target of 9860.
Name
Current Value
Change
% Chg
Open
High
Low
FTSE 100 (Jul 11)
7,329.76
-40.27
-0.55
7,370.03
7,386.88
7,304.77
CAC 40 (Jul 11)
5,140.60
-25.04
-0.49
5,172.03
5,186.44
5,135.95
DAX (Jul 11)
12,437.02
-8.9
-0.07
12,479.67
12,539.18
12,417.85
Nikkei 225 (Jul 12) Straits Times (Jul 12)
20,120.03
-75.45
-0.37
20,137.22
20,153.04
20,105.71
3,208.49
-10.31
-0.32
3,219.67
3,223.36
3,206.21
Hang Seng (Jul 12)
26,098.56
220.92
0.85
25,991.35
26,147.30
25,991.35
Taiwan Weighted (Jul 12)
10,434.65
19.08
0.18
10,396.97
10,450.87
10,393.54
SGX Nifty (Jul 12)
9,805.00
11
0.11
9,793.00
9,814.00
9,771.50
WWW.EQUITYRESEARCHLAB.COM
12th July 2017
CORPORATE NEWS Vista Pharma -US FDA issues warning letter to Vista Pharma’s Telangana unit -US FDA issues 2 observations for Telangana unit, inspected from September 19-23, 2016 -Warnings letter summarises significant violations of current good manufacturing practice regulations for finished drugs US FDA observations -Company failed to clean, maintain equipment, utensils at appropriate intervals -Company failed to establish procedures to assure drug strength, identity, quality
Adani Power says -To transfer Mundra Power unit to subsidiary -Board approved demerger of Mundra Power to a subsidiary with assets & liabilities
-SME IPOs listing - Transwind Infrastructures, Bansal Multiflex -HMT to close 3 subsidiaries and dispose of their assets -UCO Bank employees to go on strike on July 15 -Reliance Industries says Jio Prime members to enjoy all unlimited for 3 months with Rs 399 plan -Godrej Consumer Products drops soap prices up to 8 percent, expects positive in second half of FY18 -NCLT asks United Bank to clarify on Era Infra -ICICI Bank and Fairfax to sell 20 percent stake in ICICI Lombard IPO -Maruti Suzuki takes pole position in utility vehicle market in Q1FY18: Mint -Tata Global Beverage to divest stake in groups firm to parent: BS
WWW.EQUITYRESEARCHLAB.COM
12th July 2017
ERL RESEARCH TEAM Member Name
Designation
Mr. Tuhinanshu Jain Mr. Manish Bimal Mr. Anand Sharma Mr. Yash Sharma
Research Head Sr. Research Analyst Research Analyst Research Analyst
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in Stocks has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial profit s or loss which may arise from the recommendations above. The stock price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial instrument. Analyst or any person related to Equity Research Lab might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of the information is the acceptance of this disclaimer. ALL RIGHTS RESERVED.
WWW.EQUITYRESEARCHLAB.COM